INNOVATE CORP. Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31)
INNOVATE CORP. (VATE) reported Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) of $307.90 million for the 12-month period ending 2019-12-31, per its 8-K filed 2020-10-07.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue · last filed 2020-10-07
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2018-12-31 was $103.21M, a 7.99% decline year-over-year.
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2018-09-30 was $19.49M, a 84.02% decline year-over-year.
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2018-06-30 was $120.71M, a 4.60% decline year-over-year.
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2018-03-31 was $80.50M, a 33.40% decline year-over-year.
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2017 was $481.50M, a 13.74% decline from fiscal 2016.
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2016 was $558.20M, a 11.17% increase from fiscal 2015.
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2015 was $502.12M, a 231.23% increase from fiscal 2014.
- INNOVATE CORP. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2014 was $151.59M.
| Period end | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 12 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $307.90M 8-K · filed 2020-10-07 | $462.00M 10-K · filed 2020-03-16 | |||
| 2018-12-31 | $103.21M derived: 8-K 12 month − 10-Q 9 month · filed 2020-10-07 | $122.69M derived: sum of 2 quarters · filed 2020-10-07 | $243.40M derived: sum of 3 quarters · filed 2020-10-07 | $323.90M 8-K · filed 2020-10-07 | $382.90M 10-K · filed 2019-03-12 |
| 2018-09-30 | $19.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $140.20M derived: sum of 2 quarters · filed 2018-11-06 | $220.69M 10-Q · filed 2018-11-06 | $332.86M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-06-30 | $120.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $201.21M 10-Q · filed 2018-08-08 | $313.37M derived: sum of 3 quarters · filed 2019-03-12 | $435.31M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-03-31 | $80.50M 10-Q · filed 2018-05-10 | $192.66M derived: sum of 2 quarters · filed 2019-03-12 | $314.60M derived: sum of 3 quarters · filed 2019-03-12 | $441.13M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-12-31 | $112.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $234.10M derived: sum of 2 quarters · filed 2019-03-12 | $360.64M derived: sum of 3 quarters · filed 2019-03-12 | $481.50M 10-K · filed 2019-03-12 | $481.53M 10-K · filed 2018-03-14 |
| 2017-09-30 | $121.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $248.47M derived: sum of 2 quarters · filed 2018-11-06 | $369.34M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $126.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $247.40M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | $120.86M 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | $558.20M 10-K · filed 2019-03-12 | $558.18M 10-K · filed 2017-03-09 | |||
| 2015-12-31 | $342.78M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-14 | $502.12M 10-K · filed 2018-03-14 | |||
| 2015-09-30 | $159.34M 10-Q/A · filed 2016-03-15 | ||||
| 2014-12-31 | $151.59M 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TECHPRECISION CORP (TPCS) | United States | $0.053B | 108.37 |
| Proto Labs Inc (PRLB) | United States | $2.226B | 64.02 |
| Arcosa, Inc. (ACA) | United States | $7.195B | 14.51 |
| VALMONT INDUSTRIES INC (VMI) | United States | $8.988B | 22.19 |